Abstract
Simple SummaryTumors are not composed of a uniform ball of cells, but rather, a complex set of diverse cells. Unfortunately, most transcriptomic techniques analyze the entire tumor (bulk), and thus represent an average profile of genes expressed across heterogeneous cells. To estimate tumor composition from bulk data, many algorithms have been developed—broadly termed deconvolution. However, with the advent of single-cell RNA sequencing (scRNA-seq), which provides gene expression data for individual cells, a few deconvolution algorithms are now more nuanced. We have used our scRNA-seq data from head and neck tumors along with two cutting-edge deconvolution algorithms to analyze bulk expression data from >500 tumors. With this approach, we find that higher proportions of a class of immune cells (tumor-infiltrating regulatory T-cells) are associated with improved survival in head and neck cancer. Our findings and data establish a generalizable approach that can be applied across oncology to study tumor composition.Complexities in cell-type composition have rightfully led to skepticism and caution in the interpretation of bulk transcriptomic analyses. Recent studies have shown that deconvolution algorithms can be utilized to computationally estimate cell-type proportions from the gene expression data of bulk blood samples, but their performance when applied to tumor tissues, including those from head and neck, remains poorly characterized. Here, we use single-cell data (~6000 single cells) collected from 21 head and neck squamous cell carcinoma (HNSCC) samples to generate cell-type-specific gene expression signatures. We leverage bulk RNA-seq data from >500 HNSCC samples profiled by The Cancer Genome Atlas (TCGA), and using single-cell data as a reference, apply two newly developed deconvolution algorithms (CIBERSORTx and MuSiC) to the bulk transcriptome data to quantitatively estimate cell-type proportions for each tumor in TCGA. We show that these two algorithms produce similar estimates of constituent/major cell-type proportions and that a high T-cell fraction correlates with improved survival. By further characterizing T-cell subpopulations, we identify that regulatory T-cells (Tregs) were the major contributor to this improved survival. Lastly, we assessed gene expression, specifically in the Treg population, and found that TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily Member 4) was differentially expressed in the core Treg subpopulation. Moreover, higher TNFRSF4 expression was associated with greater survival, suggesting that TNFRSF4 could play a key role in mechanisms underlying the contribution of Treg in HNSCC outcomes.
Highlights
Head and neck squamous cell carcinoma (HNSCC) arises in the upper aerodigestive mucosa of the oral cavity, oropharynx, hypopharynx, larynx, and rarely, in the nasal cavity and nasopharynx [1]
Matrix established a benchmark for cell-type proportions in heterogeneous head and neck squamous cell carcinoma (HNSCC) tisSecond, we obtained the bulk RNA-seq data from >500 HNSCC samples within The Cancer Genome Atlas (TCGA) and sue
T-cells (~1000 T-cells), we examined T-cell subtypes by finer clustering, producing four sub-clusters annotated by marker genes [8] as conventional CD4 T-cells (CD4conv ; CCR7, TCF7), regulatory T-cells (Tregs ; FOXP3, CD25), conventional CD8 T-cells (CD8conv ; GZMA/B/H/K, PRF1), and exhausted CD8 T-cells (CD8exhausted ; PD1, LAG3, TIGIT, CTLA4) (Figure 3A)
Summary
Head and neck squamous cell carcinoma (HNSCC) arises in the upper aerodigestive mucosa of the oral cavity, oropharynx, hypopharynx, larynx, and rarely, in the nasal cavity and nasopharynx [1]. HNSCC is the sixth most common cancer worldwide, representing 90% of cancers that arise in the head and neck region [2,3] and accounting for 650,000 (3.6%) of cancer cases and 330,000 (3.4%) of cancer deaths per year [2]. Advancing new therapeutics for HNSCC will require insight into the cellular and molecular biology underlying HNSCC. Knowledge of cell-type composition in tumor tissues represents an important step towards identifying cellular targets in cancer. Changes in cell composition underlie diverse physiological states of complex tissues. Genes changes within particular cells might provide insights into novel avenues for treatment [6,7,8,9]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have